By otakuyassine3@gmail.com 
Adient (NYSE:ADNT – Get Free Report) had its target price upped by stock analysts at UBS Group from $19.00 to $20.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. UBS Group’s price objective would suggest a potential upside of 7.33% from the company’s previous close.
ADNT has been the topic of several other reports. StockNews.com cut Adient from a “buy” rating to a “hold” rating in a report on Wednesday, January 22nd. JPMorgan Chase & Co. reduced their price objective on shares of Adient from $24.00 to $21.00 and set a “neutral” rating on the stock in a research note on Monday. Barclays cut their price target on Adient from $24.00 to $21.00 and set an “equal weight” rating on the stock in a report on Wednesday, January 22nd. Wells Fargo & Company lowered Adient from an “overweight” rating to an “equal weight” rating and lowered their target price for the stock from $27.00 to $20.00 in a research report on Monday, December 16th. Finally, Bank of America cut shares of Adient from a “buy” rating to a “neutral” rating and cut their price target for the stock from $30.00 to $24.00 in a report on Thursday, November 21st. One investment analyst has rated the stock with a sell rating and nine have given a hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $21.88.
Get Our Latest Stock Analysis on Adient
Adient Stock Up 3.8 %
ADNT traded up $0.68 during trading hours on Wednesday, hitting $18.63. 357,881 shares of the company’s stock were exchanged, compared to its average volume of 1,292,513. Adient has a 1-year low of $16.28 and a 1-year high of $36.04. The stock has a market cap of $1.58 billion, a price-to-earnings ratio of 80.88, a PEG ratio of 0.28 and a beta of 2.16. The company has a quick ratio of 0.90, a current ratio of 1.11 and a debt-to-equity ratio of 0.98. The stock’s 50-day moving average is $18.03 and its two-hundred day moving average is $20.62.
Adient (NYSE:ADNT – Get Free Report) last released its quarterly earnings data on Tuesday, January 28th. The company reported $0.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.05). Adient had a net margin of 0.12% and a return on equity of 6.86%. During the same period last year, the firm earned $0.31 earnings per share. Sell-side analysts predict that Adient will post 2.04 earnings per share for the current fiscal year.
Insider Activity
In other Adient news, EVP James Conklin sold 11,500 shares of Adient stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $20.25, for a total transaction of $232,875.00. Following the completion of the sale, the executive vice president now directly owns 51,829 shares in the company, valued at $1,049,537.25. The trade was a 18.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 1.30% of the company’s stock.
Institutional Investors Weigh In On Adient
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. R Squared Ltd purchased a new position in shares of Adient during the 4th quarter worth approximately $32,000. US Bancorp DE increased its stake in shares of Adient by 583.8% in the 3rd quarter. US Bancorp DE now owns 1,860 shares of the company’s stock worth $42,000 after acquiring an additional 1,588 shares in the last quarter. Versant Capital Management Inc lifted its position in Adient by 10,316.7% during the 4th quarter. Versant Capital Management Inc now owns 1,875 shares of the company’s stock valued at $32,000 after acquiring an additional 1,857 shares during the period. Signaturefd LLC boosted its stake in Adient by 493.8% during the third quarter. Signaturefd LLC now owns 2,191 shares of the company’s stock worth $49,000 after acquiring an additional 1,822 shares in the last quarter. Finally, KBC Group NV grew its stake in shares of Adient by 51.8% in the 3rd quarter. KBC Group NV now owns 3,328 shares of the company’s stock worth $75,000 after buying an additional 1,136 shares during the last quarter. 92.44% of the stock is currently owned by institutional investors.
About Adient
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company’s automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Read More
Receive News & Ratings for Adient Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Adient and related companies with MarketBeat.com’s FREE daily email newsletter.